ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977

NCI, ACS, Health Departments Launch ASSIST, Goal To Cut US Smoking Rate In Half By Yr 2000

October 11, 1991

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013